Advertise on podcast: AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
Rating
5from
This podcast has
8 episodes
Language
EnglishPublisher
American Geriatrics SocietyExplicit
No
Date created
2025/10/16
Latest episode
2025/12/17
Average duration
26 min.
Release period
10 days
Description
This podcast is part of a larger online curriculum from the American Geriatrics Society developed to educate health professionals on the rapidly evolving landscape of Alzheimer’s Disease diagnosis and treatment. Each episode features a conversation between G. Michael Harper, MD, Editor-in-Chief of the AGS Alzheimer’s Disease Curriculum, and curriculum authors. Be sure to listen as they discuss topics including pathology and diagnosis, the role of neuroimaging, recent advances in amyloid-targeted therapies and monoclonal antibody treatments, discussions strategies to use with patients and families, and how to ensure equitable care for underrepresented populations in clinical trials. To access the full curriculum and other AGS resources, please visit: https://geriatricscareonline.org
Unlock AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details
Listeners
Audience numbers & engagement insights
Audience details
Podcast Insights
Podcast episodes
Check latest episodes from AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast podcast
Role of Fluid Biomarkers in the Diagnosis of Alzheimer’s Disease
2025/12/17
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Cindy Carlsson , Professor of Medicine Geriatrics at the University of Wisconsin School of Medicine and Public Health and staff physician at the Madison VA Hospital Geriatric Research, Education and Clinical Center (GRECC), Madison VA Memory Assessment Clinic, as they the role of fluid biomarkers in the Diagnosis of Alzheimer’s Disease.
To view a transcript click here, then select the transcript tab.
Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects - What Should Geriatricians Know
2025/10/17
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects.
To view a transcript click here then select the transcript tab.
The Role of Neuroimaging in Diagnosis of Alzheimer Disease
2025/10/17
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Kyra O'Brien Assistant Professor of Neurology at the Hospital of the University of Pennsylvania who, co-authored the module titled The Role of Neuroimaging in Diagnosis of Alzheimer Disease along with Jason Karlawish, MD, Professor of Medicine, medical ethics and health policy, and neurology at the University of Pennsylvania Perelman School of Medicine and Co-Associate Director of the Alzheimer’s Disease Research Center, and Co-Director of the Penn Memory Center.
To view a transcript click here then select the transcript tab.
How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters)
2025/10/16
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Halima Amjad, Associate Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine and Dr. Lolita Nidadavolu, Assistant Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, as they discuss How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters).
To view a transcript click here then select the transcript tab.
Evidence Review of FDA-Approved Monoclonal Antibody Treatments
2025/10/15
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Eric Widera of Professor of Clinical Medicine, Division of Geriatrics at UCSF and the Director of Hospice & Palliative Care at San Francisco VA Medical Center who, co-authored the module titled Evidence Review of FDA-Approved Monoclonal Antibody Treatments along with Kaitlin Willham, MD, Outpatient Geriatrics Clinic Medical Director at the San Francisco VA and Associate Professor of Medicine, at UCSF Division of Geriatrics.
To view a transcript click here then select the transcript tab.
Pathology and Diagnostic Frameworks for Alzheimer Disease
2025/10/15
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Heather E. Whitson, Distinguished Professor of Neuroscience, Professor of Medicine (Geriatrics), Director of the Duke Aging Center and the Co-director of the Duke/UNC Alzheimer’s Disease Research Center, as they discuss Pathology and Diagnostic Frameworks for Alzheimer Disease.
To view a transcript click here then select the transcript tab.
Evaluation of Cognition and Cognitive Disorder
2025/10/15
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Esther Oh, Professor of Medicine, Psychiatry and Behavioral Sciences and Pathology at the Johns Hopkins University School of Medicine and Co-Director, Johns Hopkins Memory and Alzheimer's Treatment Center and; Dr. Mfon E. Umoh, Assistant Professor in the Division of Geriatric Medicine and Gerontology at the Johns Hopkins University School of Medicine, as they discuss Evaluation of Cognition and Cognitive Disorder.
To view a transcript click here then select the transcript tab.
Advising Patients Who Are Underrepresented in Clinical Trials: Applying Care Equitably When the Evidence Is Not Inclusive
2025/10/15
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Sharon Brangman, Professor of Geriatric Medicine, Chief of the Department of Geriatrics, Director of the Center of Excellence for Alzheimer's Disease (CEAD), Director of University Geriatricians, and Chair of the Department of Geriatrics at SUNY Upstate University Hospital; and Dr. Alejandra Sanchez Lopez, Assistant Clinical Professor of Neurology and Geriatric Medicine at UCLA, as they discuss Advising Patients Who Are Underrepresented in Clinical Trials: Applying Care Equitably When the Evidence is Not Inclusive.
To view a transcript click here then select the transcript tab.
Podcast reviews
Read AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast podcast reviews
Podcast sponsorship advertising
Start advertising on AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast relevant audience podcasts
You may also like to advertise on these Podcasts
4.638601153
Modern Wisdom
Chris Williamson
4.66151303
True Crime with Kendall Rae
Mile Higher Media & Audioboom Studios
51088171
Middle Children
Jessie Jolles and Chris Burns
4.9264932000
Morning Wire
The Daily Wire
4.689251199
Get Sleepy: Sleep meditation and stories
Slumber Studios
4.79026375
Life is Short with Justin Long
Audible
4.714083346
Bad Friends
Bobby Lee & Andrew Santino
4.7124668
10 to Life
Annie Elise
4.76746460
Criminology
Emash Digital & Mike Ferguson, Mike Morford
4.87488968
The Dr. John Delony Show
Ramsey Network